青光眼光学微血管成像设备测量下限的步数分析
本研究比较了基于复杂信号的光学微血管成像(OMAGC)OCTA设备与OCT在青光眼检测中的动态范围和测量下限步数。横断面研究纳入252只青光眼眼和123只非青光眼眼,发现pPDZ、mVAD和mVSD在动态范围内约有4步,无真正测量下限,可能有助于评估晚期青光眼进展。
要点
- pPDZ估计下限最低,为-26.6 dB(SE 1.53)。
- RNFL和GCIPL到达测量下限的步数最高,分别为7.20和7.33。
- pPDZ、mVAD和mVSD约有4步,无真正测量下限,可能用于评估晚期青光眼进展。
核心结论
- pPDZ、mVAD和mVSD在动态范围内约有4步且无真正测量下限,可能有助于评估晚期青光眼进展。
- 改善OCTA的重测重复性可能增加OCTA指标的步数,从而提高其临床实用性。
研究设计与样本
- 横断面研究,纳入来自青光眼门诊的252只青光眼眼(173例患者)和123只非青光眼眼(92例受试者)。
- 使用自定义和商业软件量化OCT和OCTA指标,并进行线性变化点分析、测量下限和到达下限的步数分析。
主要发现
- 轻度青光眼(MD >-6)164只眼,中度(MD -6至-12)50只眼,重度(MD <-12)38只眼。
- pPDZ估计下限最低,为-26.6 dB(SE 1.53),其次为OCTA黄斑指标(-25至-21 dB;SE 1.03)和pVAD(-17.6 dB,SE 1.06)。
- RNFL和GCIPL的下限分别为-17.8 dB(SE 0.927)和-23.6 dB(SE 1.14)。
- 到达测量下限步数最高的是RNFL(7.20)和GCIPL(7.33),其次为pPDZ(4.25)、mVAD(3.87)和mVSD(3.81),pVAD、mPDZ和mVDZ的步数≤2.5。
临床怎么用
- pPDZ、mVAD和mVSD可能用于评估晚期青光眼进展。
- 提高OCTA重测重复性可能增加OCTA指标的步数,增强其临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare dynamic ranges and steps to measurement floors of peripapillary and macular metrics from a complex signal-based optical microangiography (OMAGC) optical coherence tomography angiography (OCTA) device for glaucoma with those of OCT measurements. DESIGN: Cross-sectional study. METHODS: Imaging of 252 eyes from 173 patients with glaucoma and 123 eyes from 92 subjects without glaucoma from a glaucoma clinic was quantified using custom and commercial software. Metrics from OCT (retinal nerve fiber layer [RNFL], ganglion cell/inner plexiform layer [GCIPL]) and OCTA (custom: peripapillary vessel area density [pVAD], macular vessel area density [mVAD], and macular vessel skeleton density [mVSD]; commercial: peripapillary perfusion density [pPDZ], macular perfusion density [mPDZ], and macular vessel density [mVDZ]) were plotted against visual field mean deviation (MD) with linear change-point analyses, measurement floors, and steps to floors. RESULTS: Mean MD (dB) for glaucomatous eyes was -5.77 (-6.45 to -5.10). The number of eyes with mild glaucoma (MD >-6), moderate glaucoma (MD -6 to -12), and severe glaucoma (MD <-12) were 164, 50, and 38, respectively. pPDZ yielded the lowest estimated floor at -26.6 dB (standard error [SE] 1.53), followed by OCTA macular metrics (-25 to -21 dB; SE 1.03) and pVAD (-17.6 dB, SE 1.06). RNFL and GCIPL produced floors at -17.8 (SE 0.927) and -23.6 dB (SE 1.14). The highest number of steps to measurement floor belonged to RNFL (7.20) and GCIPL (7.33), followed by pPDZ (4.25), mVAD (3.87), and mVSD (3.81), with 2.5 or fewer steps for pVAD, mPDZ, and mVDZ. CONCLUSIONS: pPDZ, mVAD, and mVSD had approximately 4 steps within their dynamic ranges, without true measurement floors, and thus may be useful in evaluating advanced glaucomatous progression. Improving OCTA test-retest repeatability could augment number of steps for OCTA metrics, increasing their clinical utility.
引用
- Phillips MJ, Dinh-Dang D, Bolo K, et al. Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma. Am J Ophthalmol. 2021. PMID: 34051173. doi:10.1016/j.ajo.2021.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。